Search results
Take targeted action against cancer pain
Weston Forum· 5 days agoOncologic pain is a heterogeneous phenomenon with somatic, visceral, and neural components. Effective treatment of cancer pain must take this variability...
OPINION: Russia is flooding Europe with disinformation. The U.S. elections are next.
Anchorage Daily News· 6 days agoIn 2022, European monitors who track Russian disinformation spotted an ambitious online influence...
Piper Sandler maintains target on Iovance shares, reiterates overweight By Investing.com
Investing.com· 5 days agoOn Monday, Piper Sandler expressed continued confidence in Iovance Biotherapeutics (NASDAQ:IOVA),...
Nanobiotix Announces New Data Showing Disease Control and Tumor Response in Patients Treated With...
Benzinga· 7 days agoData show favorable safety and feasibility in 68 heavily pre-treated patients with R/M-HNSCC (Intention-to-Treat population; "ITT") who received RT-activated NBTXR3 followed by anti-PD-1 as a second-or-later line
Obituaries in Springfield, MO | News-Leader
The Springfield News-Leader· 1 day agoGisele was born and raised in Ozark, Missouri, the youngest of Raymond and Gisela Drake’s three daughters. She had a distinguished career that spanned more than three decades at CoxHealth, one of the largest regional health systems in Missouri.
Case Study: Patient with Rare Breast Cancer Has Surprising Response to NAC
MedPage Today· 4 days ago"Medical Journeys" is a set of clinical resources reviewed by doctors, meant for physicians and other healthcare professionals as well as the patients they serve. Each episode of this journey ...
Promising Trial Results Show New Standards In Cancer Treatment And Diagnostics Are On The Horizon
Benzinga· 4 days agoOn Friday, Pfizer Inc PFE revealed its drug for an advanced form of lung cancer showed promising...
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 6 days agoMEDSIR's PRIMED Study Shows Promising Results for Preventing Sacituzumab Govitecan related Side Effects in the Treatment of HER2-negative Advanced Breast Cancer PR Newswire CHICAGO, June 2, ...
Researchers identify a key metabolic gene as target for improved cancer immunotherapy
Medical Xpress· 3 days agoInhibiting this gene through pharmacologic or genetic intervention led to better T-cell infiltration, increasing effectiveness of immunotherapy in a type of pancreatic cancer called PDAC. The ...
Improved Outcomes With Subcutaneous Amivantamab in NSCLC
Medscape· 7 days agoSubcutaneous amivantamab plus lazertinib may offer a survival benefit over intravenous administration, alongside dramatically reduced administration times, a new study suggests.
